Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $401.0100 (-3.71%) ($397.8150 - $421.8900) on Mon. Dec. 15, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.18% (three month average) | | RSI | 48 | | Latest Price | $401.0100(-3.71%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.6% a day on average for past five trading days. | | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(48%) XLV(38%) XBI(37%) QQQ(31%) SPY(29%) | | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities).
VIXM(-12%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.09% (StdDev 2.18%) | | Hourly BBV | 0 () | | Intraday Trend | -4.5% | | | | | |
|
| Resistance Level | $416.67 | | 5 Day Moving Average | $419.48(-4.4%) | | 10 Day Moving Average | $422.19(-5.02%) | | 20 Day Moving Average | $416.67(-3.76%) | | To recent high | -7.8% | | To recent low | 22.2% | | Market Cap | $42.519b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |